© 2022 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
The Rationale for Utilizing an Optimized Formulary to Improve the Health and Economic Outcomes of Patients with Multiple Sclerosis
In the past 15 years, with the introduction of largemolecule, biologically engineered therapies, the treatment of multiple sclerosis (MS) has been revolutionized. While still not curable, today MS is eminently treatable.